Thomas E. Waggoner

Oct 29, 2024 | jamanetwork.com | Raj R. Makkar |Aakriti Gupta |Samuel Horr |Thomas E. Waggoner

Key PointsQuestion  Are there regional differences in the association between use of cerebral embolic protection (CEP) and stroke outcomes in patients undergoing transcatheter aortic valve replacement (TAVR)? Findings  In the PROTECTED TAVR randomized clinical trial including 3000 patients, no significant difference was found in stroke rates with CEP nor in interaction by geographic region.